Brandon Twyford

News

Strategic Operational Changes Improve Patient Access to Oncology Care

10/25/2023

An abstract presented at the 2023 ASCO Quality Care Symposium evaluated the impact of a quality improvement initiative to increase patient access to care and improve the overall patient experience.

An abstract presented at the...

10/25/2023

Journal of Clinical Pathways

News

FDA Approves Pembrolizumab in Combination with Chemotherapy for Biliary Tract Cancer

11/17/2023

Brandon Twyford ;

The Food and Drug Administration (FDA) has granted approval for the use of pembrolizumab in conjunction with gemcitabine and cisplatin for locally advanced unresectable or metastatic biliary tract cancer (BTC). This decision, announced on...

The Food and Drug Administration...

11/17/2023

Journal of Clinical Pathways

News

Outpatient Chemotherapy Safety Improved Through a Multidisciplinary Quality Improvement Program

10/26/2023

Brandon Twyford ;

In this study, high alarm rates from ambulatory chemotherapy pumps that caused disruptions in dose deliveries were analyzed and a quality improvement program was initiated to address concerns over safe delivery of chemotherapy to patients.

In this study, high alarm rates...

10/26/2023

Journal of Clinical Pathways

News

Disparities in Palliative Care Access Highlighted in Nationwide Study of Deceased Lymphoma Patients

12/04/2023

Brandon Twyford ;

Nationwide study reveals that deceased lymphoma patients receiving palliative care experience significantly lower total charges but no significant impact on adjusted length of stay. The research also highlights disparities in access, with...

Nationwide study reveals that...

12/04/2023

Journal of Clinical Pathways

News

Shift to Oral Anti-Cancer Drugs Impacting OCM: Study Shows Rise in Part D Drug Expenses

10/26/2023

Brandon Twyford ;

Researchers examined the impact of the shift toward oral anti-cancer drugs and the consequent rise in costs within the Oncology Care Model. The abstract was presented at the 2023 ASCO Quality Care Symposium in Boston, Massachusetts.

Researchers examined the impact...

10/26/2023

Journal of Clinical Pathways

Conference Coverage

Study Reveals Insights into Cost-Effectiveness of Multigene Assays in Early-Stage Breast Cancer Treatment

12/06/2023

Brandon Twyford ;

A recent study presented at the 2023 ASH Annual Meeting & Exposition compared the cost-effectiveness of four multigene assays used in early-stage breast cancer treatment, and revealed which was the most beneficial for cost savings and...

A recent study presented at the...

12/06/2023

Journal of Clinical Pathways

Conference Coverage

Shift to Oral Anti-Cancer Drugs Impacting OCM: Study Shows Rise in Part D Drug Expenses

10/30/2023

Brandon Twyford ;

Researchers examined the impact...

10/30/2023

Pharmacy Learning Network

Conference Coverage

Adverse Event-Related Health Care Utilization and Cost Among Patients with HR+/HER2- Metastatic Breast Cancer

12/06/2023

Brandon Twyford ;

Research presented at SABCS 2023 examines the economic impact of treating HR+/HER2- metastatic breast cancer, revealing that costs related to adverse events in patients undergoing late-line chemotherapy treatments are significant and...

Research presented at SABCS 2023...

12/06/2023

Journal of Clinical Pathways

Conference Coverage

Rollback of Prescription Delivery Flexibilities Poses Challenges for At-Risk Cancer Patients

10/30/2023

Brandon Twyford ;

Research presented at the 2023 ASCO Quality Care Symposium revealed unequal impacts on patients from recent policy changes preventing home delivery of prescription oncology medication.

Research presented at the 2023...

10/30/2023

Pharmacy Learning Network